MetLife (NYSE:MET - Get Free Report) had its price target hoisted by Morgan Stanley from $101.00 to $109.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an "overweight" rating on the financial services provider's stock. Morgan Stanley's price target suggests a potential upside of 27.34% from the stock's previous close.
Other equities research analysts also recently issued reports about the company. JPMorgan Chase & Co. raised their price target on MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a research report on Tuesday, January 7th. Barclays dropped their price target on MetLife from $96.00 to $95.00 and set an "overweight" rating on the stock in a research report on Friday, February 7th. Keefe, Bruyette & Woods reduced their price objective on MetLife from $100.00 to $98.00 and set an "outperform" rating for the company in a research report on Wednesday, February 12th. StockNews.com lowered shares of MetLife from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Finally, BMO Capital Markets started coverage on shares of MetLife in a report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 price target for the company. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $94.58.
Read Our Latest Report on MetLife
MetLife Stock Performance
MET traded down $0.58 on Friday, hitting $85.60. The company had a trading volume of 3,114,917 shares, compared to its average volume of 3,567,300. The stock has a market cap of $58.31 billion, a price-to-earnings ratio of 14.34, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The company's fifty day moving average price is $83.73 and its 200 day moving average price is $82.08. MetLife has a 1-year low of $67.30 and a 1-year high of $89.05.
MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Equities analysts predict that MetLife will post 9.65 earnings per share for the current fiscal year.
Institutional Investors Weigh In On MetLife
Several large investors have recently modified their holdings of MET. Ball & Co Wealth Management Inc. acquired a new stake in MetLife in the 4th quarter valued at $25,000. MeadowBrook Investment Advisors LLC boosted its stake in shares of MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 220 shares in the last quarter. Transce3nd LLC bought a new stake in shares of MetLife in the 4th quarter worth about $26,000. Carmichael Hill & Associates Inc. increased its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after purchasing an additional 186 shares in the last quarter. Finally, Peterson Financial Group Inc. bought a new position in MetLife during the 3rd quarter valued at about $30,000. 94.99% of the stock is currently owned by institutional investors.
About MetLife
(
Get Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
